PIII Stock Surges 388% in May 2026 — Hits $13.20 on Strong Earnings

Quick overview

P3 Health Partners stock has shown amazing performance in the past several days. This stock has gone up strongly in the past five days and in the past one month it has gone up by 388.89 percent. On the first day of May this stock was trading at only $2.93, but after that it picked up strong upward momentum. Today on May 25, this stock has reached $13.20. Today it showed some losses, approximately 4.76 percent down, but overall its amazing performance overshadows today’s losses.

P3 Health Company Simple Introduction

Before explaining the reason behind the excellent performance of this stock, let me give you a brief introduction to this company. P3 Health Partners is basically a company that works with doctors to provide better care to their patients. Their main focus is on elderly people who use Medicare Advantage insurance. Their job is to keep their patients healthy, reduce unnecessary hospital visits, save money for insurance companies, and satisfy their patients. This company provides services in Arizona, Nevada, California and other states.

Strong Results And Debt Fix

The main reason for this huge rise is the strong Q1 2026 results announced on May 14. The company reported revenue of $386 million. They also made a good profit this quarter, which is a big improvement compared to last year when they had heavy losses.

Not only this, but the company has also largely resolved its old debt issue. On May 15, they made a deal in which instead of repaying their debt in cash, they gave shares of their own company to the people they owed money to. At the same time, they also raised an additional $30 million from new investors. Because of this deal, the company is now under much less debt and their financial situation has become much better and safer. And because of this, the company’s position in the stock market has become stronger, and the stock has risen so rapidly.

Higher Guidance And Analyst Support

Considering all these positive developments, P3 Health Partners has increased its full-year 2026 guidance. They are expecting to generate revenue between $1.5 billion to $1.65 billion, and their profit is expected to be between $20 million to $60 million.

Analysts have also liked the stock. TD Cowen and Lake Street have both increased their price target to $14, and they believe that the company is performing very well in patient care, their deals with insurance companies are going very well, and they are managing their debts and costs very efficiently. That is why many analysts have given it a Buy rating.

ABOUT THE AUTHOR See More

Arslan Butt

Lead Markets Analyst – Multi-Asset (FX, Commodities, Crypto)

Arslan Butt serves as the Lead Commodities and Indices Analyst, bringing a wealth of expertise to the field. With an MBA in Behavioral Finance and active progress towards a Ph.D., Arslan possesses a deep understanding of market dynamics. His professional journey includes a significant role as a senior analyst at a leading brokerage firm, complementing his extensive experience as a market analyst and day trader. Adept in educating others, Arslan has a commendable track record as an instructor and public speaker. His incisive analyses, particularly within the realms of cryptocurrency and forex markets, are showcased across esteemed financial publications such as ForexCrunch, InsideBitcoins, and EconomyWatch, solidifying his reputation in the financial community.